Can checkpoint inhibitors combinations replace single agent drugs?
The NLCA annual report 2017: findings for lung cancer care in the UK
Rapid access to lung cancer care in the UK: the NOLCP
Challenges for prostate cancer: overdiagnosis and unnecessary treatment
Implementing the NOLCP in the UK: all hospitals vs. diagnostic centers?